alpidem has been researched along with alprazolam in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Albizzati, MG; Bassi, S; Borghi, C; Frattola, L; Garreau, M; Morselli, PL; Piolti, R | 1 |
| Bourin, M; Hascoët, M | 1 |
1 review(s) available for alpidem and alprazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for alpidem and alprazolam
| Article | Year |
|---|---|
Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Male; Middle Aged; Neurologic Examination; Personality Assessment; Pyridines; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
2 other study(ies) available for alpidem and alprazolam
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Conflict, Psychological; GABA Modulators; Imidazoles; Male; Mice; Motor Activity; Punishment; Pyridines; Rats; Rats, Wistar | 1997 |